Glass in Prescription Injection Prompts Recall

Par Pharmaceutical Inc. is recalling 4506 packs of mycophenolate mofetil for injection, 500 mg, 4 single-dose vials (NDC 342023-172-044), after a glass fragment was found in a vial containing the reconstituted product. The recall is included in the May 15, 2019, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects vials from lot AD812 (Exp. 9/20), which were distributed throughout the United States.

Par Pharmaceutical voluntarily initiated the recall April 30, 2019. At press time, the FDA had not yet issued a recall classification. 

Mycophenolate mofetil for injection is a prescription immunosuppressant used to prevent organ rejection after transplant.

—Jolynn Tumolo